Trials / Completed
CompletedNCT01174459
Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 571 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The survey is conducted to investigate the safety and efficacy of long-term use of BI-Sifrol Tablets in Restless Legs Syndrome (RLS) patients with or without renal dysfunction in routine medical practice.
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2010-08-03
- Last updated
- 2014-08-29
- Results posted
- 2014-08-29
Locations
159 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01174459. Inclusion in this directory is not an endorsement.